2015
DOI: 10.1590/1414-431x20144262
|View full text |Cite
|
Sign up to set email alerts
|

Cell cycle synchronization and BrdU incorporation as a tool to study the possible selective elimination of ErbB1 gene in the micronuclei in A549 cells

Abstract: Lung cancer often exhibits molecular changes, such as the overexpression of the ErbB1 gene that encodes epidermal growth factor receptor (EGFR). ErbB1 amplification and mutation are associated with tumor aggressiveness and low response to therapy. The aim of the present study was to design a schedule to synchronize the cell cycle of A549 cell line (a non-small cell lung cancer) and to analyze the possible association between the micronuclei (MNs) and the extrusion of ErbB1 gene extra-copies. After double block… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
1

Year Published

2016
2016
2021
2021

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 38 publications
0
4
1
Order By: Relevance
“…To dissociate the effect of p53 on HR from its cell cycle effect, we used nocodazole-synchronized cells pulse-treated with CPT at the entrance to S phase. The doubling time of A549 cells in our hands is 38 hours with S phase lasting approximately 16 hours (unpublished data), a time slightly shorter than that reported previously [ 35 ]. A significant delay of S phase duration (up to 27 hours) was observed following pulse-treatment with CPT (Figure 3A ), with all derivatives, wild-type, p53 - or p21 Waf1 -depleted cells proceeding through S phase with a similar rate and entering G2 (Figure 3A ).…”
Section: Resultscontrasting
confidence: 51%
“…To dissociate the effect of p53 on HR from its cell cycle effect, we used nocodazole-synchronized cells pulse-treated with CPT at the entrance to S phase. The doubling time of A549 cells in our hands is 38 hours with S phase lasting approximately 16 hours (unpublished data), a time slightly shorter than that reported previously [ 35 ]. A significant delay of S phase duration (up to 27 hours) was observed following pulse-treatment with CPT (Figure 3A ), with all derivatives, wild-type, p53 - or p21 Waf1 -depleted cells proceeding through S phase with a similar rate and entering G2 (Figure 3A ).…”
Section: Resultscontrasting
confidence: 51%
“…As an analog of thymidine, BrdU is incorporated into the newly synthesized DNA of replicating cells by substituting for thymidine during DNA replication. The expression of BrdU thus identifies cells that are actively replicating their DNA 15 . We administered BrdU 4 hours before harvesting the skin of mice; thus, the expression of BrdU in these samples revealed cells that had replicated in those 4 hours.…”
Section: Discussionmentioning
confidence: 99%
“…Extrapolated growth curves were constructed over a period of fourteen days by serial passaging and cell counting with a hemocytometer or by PrestoBlue® assay (Thermo Fisher Scientific, UK). Cell proliferation was also analyzed using the CellTrace™ CFSE Cell Proliferation Kit (Invitrogen, USA) in cells synchronized by gradual serum deprivation following published protocols 25 . Cells were harvested at 48 hours and subjected to division peak resolution by flow cytometry.…”
Section: Methodsmentioning
confidence: 99%